官方服务：
资源简介：
EMERALD Trial S4. Deaths and worse ALSFRS-R outcome
应用场景：
创建时间：
2026-01-05
相关数据集
Dataset pertaining to the article "Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis"
This is the dataset pertaining to the article "Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis".
NIAID Data Ecosystem70
Additional file 12 of Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience
Additional file 12: Changes in the RULM score versus baseline for ambulant and non-ambulant patients and comparison the results.
Figshare2024-08-13 更新30
Table.Comparison of FFS value before administration of simvastatin ( after 180 minutes occlusion)
Sham: rat with ischemic stroke without simvastatin,D1:simvastatin dose 1 group, D2: simvastatin dose 2 group, D3: simvastatin dose 3 group,FFS:foot fault scoring, RHL : right hind limb,RFL: right fore
DataCite Commons2025-02-22 更新60
Table_1_Slower progression of amyotrophic lateral sclerosis with external application of a Chinese herbal plaster–The randomized, placebo-controlled triple-blinded ALS-CHEPLA trial.docx
BackgroundAmyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative disease characterized by gradually increasing damage to the upper and lower motor neurons. However, definitive and efficaci
NIAID Data Ecosystem20
